Skip to main content

March 9th 2018

Venous Thromboembolism and Cancer

We are pleased to invite you to participate in the 1st edition of “Venous Thromboembolism and Cancer”, to be held in the Instituto Português de Oncologia do Porto (IPO Porto), on March 9th 2018.

Cancer and thrombosis is an association known for more than a century. In the last years this field of research has exploded, generating an increasing and relevant amount of scientific data. The need to improve the communication and dissemination of basic and clinical research, in order to better understand the pathophysiology, prevention and treatment of venous thrombosis in cancer patients, motivated physicians and researcher from IPO Porto to organize a meeting focusing the recent advances in this issues. In this 1st edition it will discussed the biomarkers for prediction of venous thromboembolism in cancer, the thromboprophylaxis in cancer patients, the treatment of VTE and risk of recurrence, among other topics.

ProfessionalProfissional

20,00

Includes:
Meeting
Lunch
Coffee Break
 Meeting Folder
Certificate of Attendance

ResidentInterno

20,00

Includes:
Meeting
Lunch
Coffee Break
 Meeting Folder
Certificate of Attendance

StudentEstudante

20,00

Includes:
Meeting
Lunch
Coffee Break
 Meeting Folder
Certificate of Attendance

Registration available until 2ND March 2018

Scientific Programme

SCIENTIFIC PROGRAMME

Organization

Support

Organization Committee

Prof. Doutora Deolinda Pereira

Diretora do Serviço de Oncologia Médica
IPO-Porto

Dra. Luísa Santos

Diretora do Serviço de Imuno-Hematologia
IPO-Porto

Dr. Joaquim Abreu

Diretor do Serviço de Oncologia Cirúrgica
IPO-Porto

Dr. Júlio Oliveira

Assistente Hospitalar do Serviço de Oncologia Médica
IPO-Porto

Dr. Sergio Chacim

Assistente Hospitalar do Serviço de Onco-Hematologia
IPO-Porto

Scientific Sponsors

Major Sponsor

Silver Sponsor

Bronze Sponsor

Lígia Silva
(+351) 914 592 380
Jorge Pimentel
(+351) 911 542 716
Email
eventos@lab52.pt

R E G I S T R A T I O N     E N D E D!

Thank you.